用于绘制外周血微小残留病图谱的图谱集。 - Suppr | 超能文献

An ATLAS to map MRD with peripheral blood.

作者信息

Yee Andrew J

机构信息

Massachusetts General Hospital Cancer Center and Harvard Medical School.

出版信息

Blood. 2024 Aug 29;144(9):919-920. doi: 10.1182/blood.2024025189.

DOI:10.1182/blood.2024025189

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

An ATLAS to map MRD with peripheral blood.用于绘制外周血微小残留病图谱的图谱集。

Blood. 2024 Aug 29;144(9):919-920. doi: 10.1182/blood.2024025189.

2

Detection of minimal residual disease in peripheral blood prior to clinical relapse of childhood acute lymphoblastic leukaemia using PCR.运用聚合酶链反应（PCR）检测儿童急性淋巴细胞白血病临床复发前外周血中的微小残留病。

Mol Cell Probes. 2001 Apr;15(2):99-103. doi: 10.1006/mcpr.2001.0348.

3

Early (Day 15 Post Diagnosis) Peripheral Blood Assessment of Measurable Residual Disease in Flow Cytometry is a Strong Predictor of Outcome in Childhood B-Lineage Lymphoblastic Leukemia.早期（诊断后第 15 天）外周血流细胞术检测微小残留病是儿童 B 细胞淋巴母细胞白血病预后的强有力预测指标。

Cytometry B Clin Cytom. 2019 Mar;96(2):128-133. doi: 10.1002/cyto.b.21769. Epub 2019 Feb 7.

4

Measurable residual disease assessment by qPCR in peripheral blood is an informative tool for disease surveillance in childhood acute myeloid leukaemia.qPCR 检测外周血中的微小残留病灶是监测儿童急性髓系白血病疾病的一种有用工具。

Br J Haematol. 2020 Jul;190(2):198-208. doi: 10.1111/bjh.16560. Epub 2020 Mar 16.

5

Flow-cytometric minimal residual disease monitoring in blood predicts relapse risk in pediatric B-cell precursor acute lymphoblastic leukemia in trial AIEOP-BFM-ALL 2000.流式细胞术检测血液微小残留病可预测 AIEOP-BFM-ALL 2000 研究中儿童 B 细胞前体急性淋巴细胞白血病的复发风险。

Pediatr Blood Cancer. 2019 May;66(5):e27590. doi: 10.1002/pbc.27590. Epub 2018 Dec 18.

6

The significance of peripheral blood minimal residual disease to predict early disease response in patients with B-cell acute lymphoblastic leukemia.外周血微小残留病对预测B细胞急性淋巴细胞白血病患者早期疾病反应的意义。

Int J Lab Hematol. 2016 Oct;38(5):527-34. doi: 10.1111/ijlh.12535. Epub 2016 Jun 24.

7

Use of peripheral blood instead of bone marrow to monitor residual disease in children with acute lymphoblastic leukemia.使用外周血而非骨髓来监测急性淋巴细胞白血病患儿的残留疾病。

Blood. 2002 Oct 1;100(7):2399-402. doi: 10.1182/blood-2002-04-1130.

8

Peripheral blood minimal/measurable residual disease assessed in flow cytometry in acute myeloblastic leukemia.急性髓细胞白血病中通过流式细胞术评估外周血微小/可测量残留病

Leukemia. 2019 Jul;33(7):1814-1816. doi: 10.1038/s41375-019-0393-0. Epub 2019 Feb 5.

9

Minimal residual disease testing in acute leukemia by flow cytometry immunophenotyping: prognostic significance.流式细胞术免疫表型分析在急性白血病微小残留病检测中的预后意义

Lab Hematol. 2007;13(1):22-6. doi: 10.1532/LH96.06045.

10

Microfluidics for the detection of minimal residual disease in acute myeloid leukemia patients using circulating leukemic cells selected from blood.利用从血液中筛选出的循环白血病细胞，通过微流控技术检测急性髓系白血病患者的微小残留病

Analyst. 2016 Jan 21;141(2):640-51. doi: 10.1039/c5an01836f.

引用本文的文献

1

Minimal residual disease measurement in blood by mass spectrometry identifies long-term responders in multiple myeloma.通过质谱法测量血液中的微小残留病可识别多发性骨髓瘤的长期缓解者。

Blood Neoplasia. 2025 Jun 3;2(4):100124. doi: 10.1016/j.bneo.2025.100124. eCollection 2025 Nov.